Cellvizio saving livesCELLVIZIO SAVING LIVES. Changing the face of lung cancer - Valley View Hospital and Dr. Al-Zubaidi are using Cellvizio Optical Biopsy to detect lung cancer earlier than Stages 3 or 4.
Taking aim at lung cancerTAKING AIM AT LUNG CANCER. Valley View Hospital in Glennwood Springs, Colorado, is leading the charge for early detection of lung cancer using Optical Biopsy with Cellvizio. "It's like sticking a $300,000 electron microscope into your lungs,” pulmonologist Dr. Al-Zubaidi says.
Have you met EVA?HAVE YOU MET EVA? Mauna Kea Technologies introduces EVA, the Endomicroscopy Virtual Assistant that makes Optical Biopsy even more intuitive and integrated than ever before. EVA provides you with a seamless Cellvizio experience from image stabilization to review and report generation. EVA is powered by the new Cellvizio software 2.2.
Understanding Pancreatic Cysts and how Optical Biopsy can helpUNDERSTANDING PANCREATIC CYSTS AND HOW OPTICAL BIOPSY CAN HELP. Our new educational medical website aims to provide patients and families with information about pancreatic cysts and Cellvizio Optical Biopsy, a cutting-edge imaging technique that may help doctors to "see cancer faster." We hope it will be a useful resource to those faced with the possibility of a cancerous pancreatic cyst.
Turn to Optical BiopsyTURN TO OPTICAL BIOPSY. Find out how Cellvizio can benefit the lives of patients! This video depicts the use of Cellvizio to reduce risks to a patient that otherwise would have to take multiple biopsies.
Confocal laser endomicroscopy reliably detects sepsis-related and treatment-associated changes in intestinal mucosal microcirculationMicrocirculatory alterations play a central role in the pathophysiology of sepsis. We investigated probe-based confocal laser endomicroscopy (pCLE) to assess alterations in mucosal microcirculatory perfusion in vivo in a porcine model of septic shock and in patients fulfilling consensus criteria for severe sepsis.
Understanding Barrett's Esophagus and how Optical Biopsy can help.Visit our patient website dedicated to Barrett's Esophagus! Chronic acid reflux, or GERD, puts people at risk for Barrett’s Esophagus. It’s a change in the lining of the esophagus that, left untreated, can lead to cancer. If you have GERD or Barrett’s Esophagus, it is important to understand how Barrett’s develops, and the importance of a timely and accurate diagnosis so that prompt treatment can occur.
Mauna Kea Technologies Enters Into Major Cellvizio(R) Distribution Agreement With a Leading Japanese Medical Device CompanyMauna Kea Technologies reported that it has entered an exclusive distribution agreement in Japan with AMCO Inc. for a five-year period. This partnership further strengthens Mauna Kea Technologies' ties with the Japanese market, and is a major step forward in the company's efforts to obtain regulatory approval in the world's second largest endoscopy device market after the US.
16th Digestive Endoscopy Days hosted by SFED (Journée de Réflexion sur l'Endoscopie Digestive en France), Paris, France16TH DIGESTIVE ENDOSCOPY DAYS HOSTED BY SFED: During the 16th annual meeting on digestive endoscopy organized by SFED, you will have the opportunity to discover the latest version of EVA - our Endomiscroscopy Virtual Assistant, as well as the latest findings on microscopic visualization of cells in real-time with Cellvizio Optical Biopsy.
4th Endoscopic Ultrasound (EUS) Meeting/Journée du Club d'Echo-Endo, Paris, France4th ENDOSCOPIC ULTRASOUND (EUS) MEETING: Join us at the 4th Endoscopic Ultrasound (EUS) Meeting for live demonstrations from Nice, France. Discover the use of Cellvizio through needle-based Confocal Laser Endomicroscopy (nCLE) for microscopic visualization of tissues in real-time.
CELLVIZIO DAY : TRAINING WORKSHPAT UC IRVINE MEDICAL CENTERAcquire an understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duct, pancreas and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed
MAUNA KEA TECHNOLOGIES RECEIVES THE VISIT OF FRENCH PRESIDENT, FRANCOIS HOLLANDEParis, 2nd December 2013 - Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in optical biopsy market and the maker of Cellvizio®, the fastest way to see cancer, today announced that the French President, François Hollande and Ms Anne Lauvergeon, President of the “Innovation 2030” Commission visited the company’s headquarters this morning.